New diabetes clinical trial: Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Published on: July 23, 2019 at 07:00PM
Conditions:   Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1
Interventions:   Drug: 3 hours humulin R 100 IU/mL PIT;   Drug: 2 hours humulin R 100 IU/mL PIT
Sponsors:   Sciema UG;   Innovative Diabetes Treatment Studies LLC.
Not yet recruiting